Clinical Trial Update: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacokinetic/pharmacodynamic characteristics and safety between AD-120 and AD-120A in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• AD-120
• AD-120A

Snippet

Sponsor: Addpharma Inc. | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 1 | Status: NOT_YET_RECRUITING